Back to the complete issue
Wednesday, 2 March 2022

Daily cases, hospitalizations fall + Trials commence on our second homegrown jab

The Health Ministry reported 1,322 new covid-19 infections yesterday, down from 1,523 the day before. Egypt has now disclosed a total of 485,093 confirmed cases of covid-19. The ministry also reported 36 new deaths, bringing the country’s total death toll to 24,110.

Daily cases have now been declining steadily for over three weeks, from a peak of 2.3k on 6 Feb, as the omicron wave subsides.

Another sign we’re well over the worst of omicron: Covid hospitalizations are down by almost half nationwide. Covid-19-related hospital admissions saw a 40% drop across the country in the two weeks up to 25 February, compared to the preceding two weeks, Acting Minister of Health Khaled Abdel-Ghaffar said, according to a ministry statement.

Egyvax clinical trials kick off: Forty-five volunteers will be given doses of Egypt’s second experimental covid-19 vaccine, Egyvax, in clinical trials that launched yesterday, according to a Higher Education and Scientific Research Ministry statement. If all goes well, production is set to start by the end of this year, with an expected capacity of 500 mn doses annually for both domestic use and export, the statement read. The new jab is set to be manufactured by Eva Pharma, which is currently a local manufacturer of Sinovac vaccines.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.